RNE, M., MA, N., MG, H., SE, A., & ME, A. (2025). Protective effect of Dulaglutide, a GLP1 agonist, on acetic acid-induced ulcerative colitis in rats: Involvement of GLP-1, TFF-3, and TGF-β/PI3K/NF-κB signaling pathway. Naunyn-Schmiedeberg's archives of pharmacology, 398(5), 5611. https://doi.org/10.1007/s00210-024-03631-5
Chicago Style (17th ed.) CitationRNE, Mahdy, Nader MA, Helal MG, Abu-Risha SE, and Abdelmageed ME. "Protective Effect of Dulaglutide, a GLP1 Agonist, on Acetic Acid-induced Ulcerative Colitis in Rats: Involvement of GLP-1, TFF-3, and TGF-β/PI3K/NF-κB Signaling Pathway." Naunyn-Schmiedeberg's Archives of Pharmacology 398, no. 5 (2025): 5611. https://doi.org/10.1007/s00210-024-03631-5.
MLA (9th ed.) CitationRNE, Mahdy, et al. "Protective Effect of Dulaglutide, a GLP1 Agonist, on Acetic Acid-induced Ulcerative Colitis in Rats: Involvement of GLP-1, TFF-3, and TGF-β/PI3K/NF-κB Signaling Pathway." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 398, no. 5, 2025, p. 5611, https://doi.org/10.1007/s00210-024-03631-5.